# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-263618
Filing Date
2025-11-04
Accepted
2025-11-04 08:00:50
Documents
61
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | hrtx-20250930.htm iXBRL | 10-Q | 2368959
2 | EX-10.1 | hrtx-ex10_1.htm | EX-10.1 | 242927
3 | EX-10.7 | hrtx-ex10_7.htm | EX-10.7 | 1039506
4 | EX-10.8 | hrtx-ex10_8.htm | EX-10.8 | 23712
5 | EX-31.1 | hrtx-ex31_1.htm | EX-31.1 | 17480
6 | EX-31.2 | hrtx-ex31_2.htm | EX-31.2 | 17226
7 | EX-32.1 | hrtx-ex32_1.htm | EX-32.1 | 19365
| Complete submission text file | 0001193125-25-263618.txt |  | 10419869

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | hrtx-20250930.xsd | EX-101.SCH | 996612
64 | EXTRACTED XBRL INSTANCE DOCUMENT | hrtx-20250930_htm.xml | XML | 1716698

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 251446510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)